Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Oxiranchem is a China-based specialty chemicals company focused on the research, production, and sale of ethylene oxide derivatives and related fine chemicals. Its core portfolio includes polyether monomers, polyethylene glycol, ethylene carbonate, dimethyl carbonate, surfactants, and other functional materials used across construction, cleaning, battery materials, electronics, and industrial applications. The group also has a pharmaceutical excipients business that manufactures medical-grade polyethylene glycol and related derivatives under GMP-oriented quality systems. Although it has some healthcare-adjacent products through excipients, the company is primarily an industrial and materials chemistry business rather than a biotech or pharmaceutical drug developer. The company is publicly listed in China and appears to remain operational as part of Oxiranchem Holding Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liaoning Oxiranchem.